´ëÇ¥¼Àû
Ä¡¸Å±³°ú¼ (Ä¡¸Å-ÀÓ»óÀû Á¢±Ù)
- ÀúÀÚ(±Û)´ëÇÑÄ¡¸ÅÇÐȸ
- ÃâÆÇ»ç´ëÇÑÀÇÇмÀû
- ¹ßÇàÀÏ2006³â 4¿ù
Ä¡¸Å¿Í ¼ö¸éÀÇ °ü·Ã¼º ¿¬±¸ÇØ Çа迡 ¼Ò°³
| Á¦ ¸ñ | Association between APOE ¥å2 and A¥â burden in patients with Alzheimer- and vascular-type cognitive impairment |
|---|---|
| ¹ßÇ¥³âµµ | 2020.1 |
| ¹ßÇ¥Áö |
| Á¦ ¸ñ | Interactive Effects of Apolipoprotein E epsilon 4 and Triiodothyronine on Memory Performance in Patients With Subjective Cognitive Decline |
|---|---|
| ¹ßÇ¥³âµµ | 2020.06 |
| ¹ßÇ¥Áö |
| Á¦ ¸ñ | Differences in neuroimaging features of early-versus late-onset nonfluent/agrammatic primary progressive aphasia |
|---|---|
| ¹ßÇ¥³âµµ | 2020.02 |
| ¹ßÇ¥Áö |
| Á¦ ¸ñ | A Comparison Study of Cilostazol and Aspirin on Changes in Volume of Cerebral Small Vessel Disease White Matter Changes: Protocol of a Multicenter, Randomized Controlled Trial |
|---|---|
| ¹ßÇ¥³âµµ | 2019.12 |
| ¹ßÇ¥Áö |
| Á¦ ¸ñ | Cognition enhancing effect of panax ginseng in Korean volunteers with mild cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial |
|---|---|
| ¹ßÇ¥³âµµ | 2019.09 |
| ¹ßÇ¥Áö |
| Á¦ ¸ñ | ´ÜÀÏ ±â°ü¿¡¼ °æÇèÇÑ ºñ±â¾ï»ó½ÇÇü °æµµ ÀÎÁöÀå¾ÖÀÇ ÀÓ»óÀû °íÂû |
|---|---|
| ¹ßÇ¥³âµµ | 2019.08 |
| ¹ßÇ¥Áö |
| Á¦ ¸ñ | Distinct Brain Regions in Physiological and Pathological Brain Aging |
|---|---|
| ¹ßÇ¥³âµµ | 2019.06 |
| ¹ßÇ¥Áö |

°æÈñ´ëÇб³º´¿øÀº ȯÀÚ Áß½ÉÀÇ ÀÇ·á ¼ºñ½º¸¦ Á¦°øÇϸç, ±¹³» ÀÇ·á°è¸¦ ¼±µµÇÏ´Â »ó±ÞÁ¾ÇÕº´¿øÀÔ´Ï´Ù. ÃֽŠÀÇ·á ±â¼ú°ú Àåºñ¸¦ Ȱ¿ëÇÏ¿© ȯÀڵ鿡°Ô ÃÖ»óÀÇ Ä¡·á¸¦ Á¦°øÇÕ´Ï´Ù. ƯÈ÷ ÁßÁõÁúȯ Ä¡·á ¹× ¿¬±¸¿¡ °Á¡À» º¸À̸ç, ´ÙÇÐÁ¦ ÇùÁø ½Ã½ºÅÛÀ» ÅëÇØ ȯÀÚÀÇ °Ç°À» ÃÖ¿ì¼±À¸·Î »ý°¢ÇÕ´Ï´Ù. °æÈñ´ëÇб³º´¿øÀº ȯÀÚµéÀÇ ½Å·Ú¿Í ¸¸Á·µµ¸¦ ³ôÀÌ´Â µ¥ ÁÖ·ÂÇϸç, Áö¼ÓÀûÀ¸·Î ÀÇ·á ǰÁú Çâ»ó°ú ¿¬±¸ °³¹ß¿¡ Èû¾²°í ÀÖ½À´Ï´Ù.
¼¿ïƯº°½Ã µ¿´ë¹®±¸ °æÈñ´ë·Î 23 °æÈñ´ëÇб³º´¿ø